Sector pending / Nonstore RetailersUpdated 2026-05-10 22:07 UTC

FRA/8ZN stock hub

FRA/8ZN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/8ZNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.9B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/8ZN

In the news

Latest news · FRA/8ZN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.2

P25 n/aP50 n/aP75 n/a

Trailing P/E24.2

P25 n/aP50 n/aP75 n/a

ROE9.3

P25 n/aP50 n/aP75 n/a

ROIC26.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/8ZN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

CNY

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	5,263
Employees Change	1,008%
Employees Change Percent	28.28
Enterprise value	EUR 10.1B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Nonstore Retailers
Last refreshed	2026-05-10
Market cap	EUR 15.9B
Price	EUR 4.85
Price currency	EUR
Rev Per Employee	1,699,199.12x
Sic	5960
Symbol	fra/8ZN
Website	https://ir.jdhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.12%
EV Earnings	15.48x
EV/EBIT	22.46x
EV/EBITDA	20.9x
EV/FCF	8.3x
EV/Sales	1.14x
FCF yield	7.69%
Forward P/E	19.15x
P/B ratio	2.17x
P/E ratio	24.24x
P/S ratio	1.77x
PE Ratio10 Y	85.26x
PE Ratio3 Y	27.88x
PE Ratio5 Y	34.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.17%
EBITDA Margin	5.41%
FCF margin	13.65%
Gross margin	24.78%
Gross Profit	EUR 2.2B
Gross Profit Growth	17.41%
Gross Profit Growth Q	40.83%
Gross Profit Growth3 Y	13.76%
Gross Profit Growth5 Y	9.28%
Net Income	EUR 654.6M
Net Income Growth	29.16%
Net Income Growth Q	30.8%
Net Income Growth3 Y	27.11%
Net Income Growth5 Y	25.63%
Pretax Margin	8.21%
Profit Margin	7.32%
Profit Per Employee	EUR 124,370
ROA	3.11
Roa5y	0.55
ROCE	6.24
ROE	9.31
Roe5y	4
ROIC	26.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.28%
Cagr3y	-8.65%
Cagr5y	-16.77%
EPS Growth	27.27
EPS Growth Q	29.84
EPS Growth3 Y	26.22
EPS Growth5 Y	25.44
FCF Growth	133.85%
FCF Growth Q	84.36%
FCF Growth3 Y	15.94%
FCF Growth5 Y	20.42%
OCF Growth	134.84%
OCF Growth Q	86.91%
OCF Growth10 Y	10.65%
OCF Growth3 Y	16.31%
OCF Growth5 Y	20.42%
Revenue Growth	26.28x
Revenue Growth Q	27.96x
Revenue Growth3 Y	10.28x
Revenue Growth5 Y	6.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.96
Assets	EUR 9.9B
Cash	EUR 5.9B
Current Assets	EUR 7B
Current Liabilities	EUR 2.6B
Debt	EUR 77.4M
Debt EBITDA	EUR 0.16
Debt Equity	EUR 0.01
Debt FCF	EUR 0.06
Equity	EUR 7.3B
Interest Coverage	342.2
Liabilities	EUR 2.6B
Long Term Assets	EUR 2.9B
Long Term Liabilities	EUR 33.5M
Net Cash	EUR 5.8B
Net Cash By Market Cap	EUR 36.46
Net Cash Growth	-6.79%
Net Debt EBITDA	EUR -11.95
Net Debt Equity	EUR -0.79
Net Debt FCF	EUR -4.74
Tangible Book Value	EUR 7.1B
Tangible Book Value Per Share	EUR 2.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.72
Inventory Turnover	8.7
Net Working Capital	EUR -1.5B
Quick ratio	2.37
Working Capital	EUR 4.3B
Working Capital Turnover	EUR 0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.27%
200-day SMA	6.35
3Y total return	-23.79%
50-day SMA	5.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.07%
All Time High	23.39
All Time High Change	-79.27%
All Time High Date	2020-12-22
All Time Low	2.28
All Time Low Change	112.63%
All Time Low Date	2024-08-15
ATR	0.11
Ch YTD	-19.87
High	4.85
High52	7.7
High52 Date	2025-09-19
High52ch	-37.04%
Low	4.85
Low52	4.16
Low52 Date	2025-05-09
Low52ch	16.54%
Ma50ch	-8.82%
Price vs 200-day SMA	-23.61%
RSI	37.85
RSI Monthly	45.72
RSI Weekly	35.16
Sharpe ratio	0.45x
Sortino ratio	0.84
Total Return	-1.14%
Tr YTD	-19.87
Tr1m	-9.55%
Tr1w	-2.44%
Tr3m	-23.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 462.5M
Operating Income Growth	68.43
Operating Income Growth Q	1,206.5
Operating Income Growth3 Y	69.02
Operating Income Growth5 Y	40.85
Operating margin	5.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,034,827,717%
Net Borrowing	-8,485,230.9
Shares Insiders	0.83%
Shares Institutions	15.71%
Shares Qo Q	0.41%
Shares Yo Y	1.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.1B
Average Volume	470.45x
Bv Per Share	2.31
CAPEX	EUR -18.4M
Ch1m	-9.55
Ch1w	-2.45
Ch1y	13.27
Ch3m	-23.05
Ch3y	-23.79
Ch5y	-60.07
Ch6m	-28.18
Change	-3.5%
Change From Open	0
Close	5.02
Days Gap	-3.5
Depreciation Amortization	22,107,758.8
Earnings Date	2026-05-15
EBIT	EUR 462.5M
EBITDA	EUR 484.1M
EPS	EUR 0.2
F Score	6
FCF	EUR 1.2B
FCF EV Yield	12.05x
Financing CF	-9,638,126
Fiscal Year End	December
Founded	2,014
Graham Number	3.17104
Graham Upside	-34.59
Income Tax	EUR 80.7M
Investing CF	-71,922,889
Is Primary Listing	0
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Lynch Fair Value	EUR 5
Lynch Upside	3.12
Ma150	6.27
Ma150ch	-22.63%
Ma20	5.11
Ma20ch	-5.16%
Net CF	1,114,890,817
Next Earnings Date	2026-05-15
Open	4.85
P FCF Ratio	13
P OCF Ratio	12.81
Ppne	153,384,764.9
Price Date	2026-05-08
Price EBITDA	EUR 32.78
Ptbv Ratio	2.24
Relative Volume	0.39x
Revenue	8,942,884,974x
SBC By Revenue	0.8x
Share Based Comp	71,931,779
Tax By Revenue	0.9x
Tax Rate	10.99%
Tr6m	-28.18%
Z Score	5.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/8ZN pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/8ZN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/8ZN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.7%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.1%

Negative means the company is buying back shares.

Technical

FRA/8ZN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.9

Neutral momentum band

Price vs 200-day MA

-23.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/8ZN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8ZN stock rating?

fra/8ZN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8ZN analysis?

The full report lives at /stocks/fra/8ZN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8ZN?

The latest report frames fra/8ZN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8ZN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.